Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic evaluation in palliative care: final results from a prospective cohort study.
Ermacora P, Mazzer M, Isola M, Pascoletti G, Gregoraci G, Basile D, De Carlo E, Merlo V, Luz O, Cattaruzza M, Orlando A, Bozza C, Pella N, Sacco CS, Puglisi F, Fasola G, Aprile G. Ermacora P, et al. Among authors: de carlo e. Support Care Cancer. 2019 Jun;27(6):2095-2102. doi: 10.1007/s00520-018-4463-z. Epub 2018 Sep 18. Support Care Cancer. 2019. PMID: 30229339
Immunotherapy for colorectal cancer: where are we heading?
Basile D, Garattini SK, Bonotto M, Ongaro E, Casagrande M, Cattaneo M, Fanotto V, De Carlo E, Loupakis F, Urbano F, Negri FV, Pella N, Russano M, Brunetti O, Scartozzi M, Santini D, Silvestris N, Casadei Gardini A, Puzzoni M, Calvetti L, Cardarelli N, Aprile G. Basile D, et al. Among authors: de carlo e. Expert Opin Biol Ther. 2017 Jun;17(6):709-721. doi: 10.1080/14712598.2017.1315405. Epub 2017 Apr 13. Expert Opin Biol Ther. 2017. PMID: 28375039 Free article. Review.
Second-line chemotherapy for advanced pancreatic cancer: Which is the best option?
Aprile G, Negri FV, Giuliani F, De Carlo E, Melisi D, Simionato F, Silvestris N, Brunetti O, Leone F, Marino D, Santini D, Dell'Aquila E, Zeppola T, Puzzoni M, Scartozzi M. Aprile G, et al. Among authors: de carlo e. Crit Rev Oncol Hematol. 2017 Jul;115:1-12. doi: 10.1016/j.critrevonc.2017.03.025. Epub 2017 Apr 20. Crit Rev Oncol Hematol. 2017. PMID: 28602164 Review.
Determinants of Last-line Treatment in Metastatic Breast Cancer.
Cinausero M, Gerratana L, De Carlo E, Iacono D, Bonotto M, Fanotto V, Buoro V, Basile D, Vitale MG, Rihawi K, Fasola G, Puglisi F. Cinausero M, et al. Among authors: de carlo e. Clin Breast Cancer. 2018 Jun;18(3):205-213. doi: 10.1016/j.clbc.2017.07.008. Epub 2017 Jul 14. Clin Breast Cancer. 2018. PMID: 28781022
INTEGRATED CARE PATHWAYS IN LUNG CANCER: A QUALITY IMPROVEMENT PROJECT.
Fasola G, Menis J, Follador A, De Carlo E, Valent F, Aresu G, De Pellegrin A, Giacomuzzi F, Iuri D, Lugatti E, Parisi G, Pacileo G. Fasola G, et al. Among authors: de carlo e, de pellegrin a. Int J Technol Assess Health Care. 2018 Jan;34(1):3-9. doi: 10.1017/S026646231700441X. Epub 2018 Feb 6. Int J Technol Assess Health Care. 2018. PMID: 29405098
176 results